Lifeward (LFWD) Return on Capital Employed Growth (1y) (2017 - 2026)
Lifeward (LFWD) Return on Capital Employed Growth (1y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.33 Bn | 174.04 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 128.11 Bn | 125.23 Bn | 3.81 Bn | -1,390.00 |
| 3 | Medtronic | 107.76 Bn | 98.54 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 67.95 Bn | 66.50 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | -110.00 |
| 6 | GE HealthCare Technologies | 28.43 Bn | 26.14 Bn | 1.98 Bn | -3,185.00 |
| 7 | Dexcom | 28.31 Bn | 27.20 Bn | 750.30 Mn | 658.00 |
| 8 | Smith & Nephew | 26.77 Bn | 26.19 Bn | - | - |
| 9 | Koninklijke Philips | 25.33 Bn | 22.21 Bn | 2.07 Bn | 125.00 |
| 10 | Lifeward | 10.92 Mn | -499,629.84 | 1.34 Mn | -896.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -896.00 |
| Dec 31, 2025 | -7,376.00 |
| Sep 30, 2025 | -13,478.00 |
| Jun 30, 2025 | -11,302.00 |
| Mar 31, 2025 | -8,220.00 |
| Dec 31, 2024 | -6,178.00 |
| Sep 30, 2024 | -1,122.00 |
| Jun 30, 2024 | -2,578.00 |
| Mar 31, 2024 | -2,407.00 |
| Dec 31, 2023 | -1,713.00 |
| Sep 30, 2023 | -1,842.00 |
| Jun 30, 2023 | -1,421.00 |
| Mar 31, 2023 | -1,265.00 |
| Dec 31, 2022 | -1,262.00 |
| Sep 30, 2022 | -832.00 |
| Jun 30, 2022 | -60.00 |
| Mar 31, 2022 | 847.00 |
| Dec 31, 2021 | 3,974.00 |
| Sep 30, 2021 | 5,952.00 |
| Jun 30, 2021 | 6,456.00 |